Efficacy and safety of gemigliptin/metformin initial combination therapy versus either as monotherapy in drug-naive patients with type 2 diabetes

被引:0
|
作者
Lim, S. [1 ]
Min, K. [2 ]
Yu, J. -M. [3 ]
Chamnan, P. [4 ]
Kim, E. [5 ,13 ]
Yoon, K. -H. [6 ]
Kwon, S. [7 ]
Moon, M. [8 ]
Lee, K. [9 ]
Kim, D. -J. [10 ]
Kim, M. [11 ]
Wongtanate, M. [12 ]
Kim, E. [5 ,13 ]
Kim, S. -H. [13 ]
Lee, M. -K. [14 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Songnam, South Korea
[2] Eulji Univ, Med Ctr, Seoul, South Korea
[3] Kangnam Sacred Heart Hosp, Seoul, South Korea
[4] Sunpasitthiprasong Hosp, Ubon Ratchathani, Thailand
[5] Ulsan Univ Hosp, Ulsan, South Korea
[6] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea
[7] Samsung Changwon Hosp, Chang Won, South Korea
[8] Seoul Natl Univ, Boramae Med Ctr, Seoul, South Korea
[9] Ajou Univ Hosp, Suwon, South Korea
[10] Inje Univ, Ilsan Paik Hosp, Goyang, South Korea
[11] Inje Univ, Haeundae Paik Hosp, Busan, South Korea
[12] Nan Hosp, Nan, Thailand
[13] LG Life Sci, Seoul, South Korea
[14] Sungkyunkwan Univ, Samsung Med Ctr, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
109
引用
收藏
页码:S54 / S54
页数:1
相关论文
共 50 条
  • [1] EFFECTS OF GEMIGLIPTIN VERSUS SITAGLIPTIN OR GLIMEPIRIDE ON GLYCEMIC VARIABILITY AS INITIAL COMBINATION THERAPY WITH METFORMIN IN DRUG-NAIVE PATIENTS WITH TYPE 2 DIABETES
    Park, S. E.
    Lee, B. -W.
    Kim, J. H.
    Jung, C. H.
    Lee, S. -H.
    Suh, S. H.
    Lee, W. J.
    Jang, Y. H.
    Kim, S. -H.
    Park, C. -Y.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 106 : S139 - S139
  • [2] Effects of gemigliptin versus sitagliptin or glimepiride on glycaemic variability as initial combination therapy with metformin in drug-naive patients with type 2 diabetes
    Lee, B. -W.
    Kim, J.
    Park, S.
    Jung, C.
    Lee, S. -H.
    Suh, S.
    Lee, W.
    Cho, J. -H.
    Jang, Y.
    Kim, S. -H.
    Park, C. -Y.
    [J]. DIABETOLOGIA, 2015, 58 : S387 - S387
  • [3] Initial Combination Therapy With Canagliflozin Plus Metformin Versus Each Component as Monotherapy for Drug-Naive Type 2 Diabetes
    Rosenstock, Julio
    Chuck, Leonard
    Gonzalez-Ortiz, Manuel
    Merton, Kate
    Craig, Jagriti
    Capuano, George
    Qiu, Rong
    [J]. DIABETES CARE, 2016, 39 (03) : 353 - 362
  • [4] Initial combination therapy with saxagliptin and metformin improves glycaemic control compared with either monotherapy alone in drug-naive patients with type 2 diabetes
    Chen, R.
    Pfuetzner, A.
    Jadzinsky, M.
    Paz-Pacheco, E.
    Xu, Z.
    Allen, E.
    [J]. DIABETOLOGIA, 2008, 51 : S38 - S38
  • [5] Efficacy and safety of initial combination therapy with alogliptin plus metformin versus either as monotherapy in drug-naive patients with type 2 diabetes: a randomized, double-blind, 6-month study
    Pratley, R. E.
    Fleck, P.
    Wilson, C.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (07): : 613 - 621
  • [6] Efficacy and safety of linagliptin/metformin fixed-dose combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Gong, Y.
    Mu, Y.
    Fan, B.
    Hehnke, U.
    Pan, C.
    [J]. DIABETOLOGIA, 2015, 58 : S388 - S388
  • [7] Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naive Asian patients with type 2 diabetes
    Mu, Yiming
    Pan, Changyu
    Fan, Bei
    Hehnke, Uwe
    Zhang, Xiuzhen
    Zhang, Xuejun
    Wang, Xiaoyue
    Liu, Jingdong
    Zhang, Ying
    Du, Jianling
    Ma, Jianhua
    Gong, Yan
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2017, 124 : 48 - 56
  • [8] Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study)
    Lim, Soo
    Han, Kyung Ah
    Yu, JaeMyung
    Chamnan, Parinya
    Kim, Eun Sook
    Yoon, Kun-Ho
    Kwon, Sam
    Moon, Min Kyong
    Lee, Kwan Woo
    Kim, Dong-Jun
    Kim, Mikyung
    Wongtanate, Manaj
    Kim, Eun Young
    Kim, Sung-Ho
    Lee, Moon-Kyu
    [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (01): : 87 - 97
  • [9] Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Lobeglitazone in Drug-Naive Patients with Type 2 Diabetes
    Kim, Kyoung Min
    Lee, Seo Young
    Lee, Ji Hyun
    Lee, Dong Hwa
    Oh, Tae Jung
    Jang, Hak Chul
    Lim, Soo
    [J]. DIABETES, 2017, 66 : A346 - A346
  • [10] Efficacy and Safety of Exenatide Once Weekly Versus Metformin, Pioglitazone, and Sitagliptin Used as Monotherapy in Drug-Naive Patients with Type 2 Diabetes
    Cuddihy, Robert M.
    Russell-Jones, David
    Hanefeld, Markolf
    Kumar, Ajay
    Gonzalez, Jose G.
    de Teresa, Luis
    Boardman, Marilyn
    Chan, Melanie
    Wolka, Anne M.
    Porter, Lisa
    [J]. DIABETES, 2011, 60 : A77 - A77